The HPV mRNA (All High-Risk Subtypes) test is a diagnostic test used to detect the presence of messenger RNA (mRNA) from high-risk subtypes of Human Papillomavirus (HPV). This test focuses on the expression of E6/E7 viral oncogenes, which are indicative of active viral infection and potential progression to cancer. The test is important because it provides a highly specific method for detecting active high-risk HPV infections. It plays a critical role in risk stratification, guiding clinical management, early detection of precancerous lesions, and informing public health strategies. This test enhances the effectiveness of cervical cancer screening programs and helps reduce the burden of HPV-related cancers.
